As of February 2026 Regeneron Pharmaceuticals has a market cap of A$118.31 Billion. This makes Regeneron Pharmaceuticals the world's 280th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 7th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be: